FDA.reportPublic FDA data

levothyroxine sodium 0.8 MG Oral Tablet [Thyro-Tabs]

RxCUI
1189695
RxNorm name
levothyroxine sodium 0.8 MG Oral Tablet [Thyro-Tabs]
Term type
SBD
Status
Active
Updated
2026-11-04 11:51:48

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
112011
Active start
112011
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
levothyroxine sodium0.8 MG / 1 EACHlevothyroxinelevothyroxine sodium

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
levothyroxine10582

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRThyro-Tabs 0.8 MG Oral Tablet1NAMES
RxNorm Namelevothyroxine sodium 0.8 MG Oral Tablet [Thyro-Tabs]1NAMES
RxNorm SynonymThyro-Tabs 0.8 MG Oral Tablet1NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID
3 linked values
3CODES
RxCUI11896951CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 7 matching rows.

NDC11, Source, Active table
NDC11SourceActive
11695696401rxnav_ndcsyes
11695696402rxnav_ndcsyes
11789025810rxnav_ndcsyes
11789025820rxnav_ndcsyes
13985098810rxnav_ndcsyes
13985098820rxnav_ndcsyes
11789025850rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
38005382-289a-4293-b58e-b1cda8bc2288Thyro-Tabs Canine 0.8 MG Oral Tablet [PSN] · levothyroxine sodium 0.8 MG Oral Tablet [Thyro-Tabs] [SBD] · Thyro-Tabs 0.8 MG Oral Tablet [SY]37Thyro-Tabs ® Canine (levothyroxine sodium tablets), USP20230928
32cdd7ba-aa35-49d0-90ce-0ee4c0b4d310Thyro-Tabs Canine 0.8 MG Oral Tablet [PSN] · levothyroxine sodium 0.8 MG Oral Tablet [Thyro-Tabs] [SBD] · Thyro-Tabs 0.8 MG Oral Tablet [SY]36Thyro-Tabs ® Canine (levothyroxine sodium tablets), USP20241017
d7defad6-dcb9-4d16-8129-7f0c196569d8Thyro-Tabs Canine 0.8 MG Oral Tablet [PSN] · levothyroxine sodium 0.8 MG Oral Tablet [Thyro-Tabs] [SBD] · Thyro-Tabs 0.8 MG Oral Tablet [SY]32Thyro-Tabs ® Canine (levothyroxine sodium tablets), USP20231002

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
38005382-289a-4293-b58e-b1cda8bc2288Thyro-Tabs ® Canine (levothyroxine sodium tablets), USPLLOYD, Inc. of Iowa20261002
32cdd7ba-aa35-49d0-90ce-0ee4c0b4d310Thyro-Tabs ® Canine (levothyroxine sodium tablets), USPMWI/VetOne | LLOYD, Inc. of Iowa20261002
d7defad6-dcb9-4d16-8129-7f0c196569d8Thyro-Tabs ® Canine (levothyroxine sodium tablets), USPButler Animal Health Supply, LLC. | LLOYD, Inc. of Iowa20261002
32cdd7ba-aa35-49d0-90ce-0ee4c0b4d310Thyro-Tabs ® Canine (levothyroxine sodium tablets), USPMWI/VetOne | LLOYD, Inc. of Iowa20241017
d7defad6-dcb9-4d16-8129-7f0c196569d8Thyro-Tabs ® Canine (levothyroxine sodium tablets), USPButler Animal Health Supply, LLC. | LLOYD, Inc. of Iowa20231002
38005382-289a-4293-b58e-b1cda8bc2288Thyro-Tabs ® Canine (levothyroxine sodium tablets), USPLLOYD, Inc. of Iowa20230928

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCH03AAThyroid hormonesATC1-4levothyroxine sodium
FDASPLD013974ThyroxineCHEMhas_chemical_structurelevothyroxine
FDASPLN0000175945l-ThyroxineEPChas_epclevothyroxine
MEDRTD013974ThyroxineCHEMhas_ingredientlevothyroxine sodium
MEDRTD013974ThyroxineCHEMhas_ingredientlevothyroxine
MEDRTD000309Adrenal InsufficiencyDISEASEci_withlevothyroxine
MEDRTD000309Adrenal InsufficiencyDISEASEci_withlevothyroxine sodium
MEDRTD004342Drug HypersensitivityDISEASEci_withlevothyroxine
MEDRTD004342Drug HypersensitivityDISEASEci_withlevothyroxine sodium
MEDRTD006042GoiterDISEASEmay_treatlevothyroxine
MEDRTD006042GoiterDISEASEmay_treatlevothyroxine sodium
MEDRTD007037HypothyroidismDISEASEmay_preventlevothyroxine
MEDRTD007037HypothyroidismDISEASEmay_preventlevothyroxine sodium
MEDRTD009203Myocardial InfarctionDISEASEci_withlevothyroxine sodium
MEDRTD009203Myocardial InfarctionDISEASEci_withlevothyroxine
MEDRTD009230MyxedemaDISEASEmay_treatlevothyroxine sodium
MEDRTD009230MyxedemaDISEASEmay_treatlevothyroxine
MEDRTD013959Thyroid DiseasesDISEASEmay_diagnoselevothyroxine
MEDRTD013959Thyroid DiseasesDISEASEmay_diagnoselevothyroxine sodium
MEDRTD013964Thyroid NeoplasmsDISEASEmay_treatlevothyroxine
MEDRTD013964Thyroid NeoplasmsDISEASEmay_treatlevothyroxine sodium
MEDRTD013967Thyroiditis, AutoimmuneDISEASEmay_treatlevothyroxine sodium
MEDRTD013967Thyroiditis, AutoimmuneDISEASEmay_treatlevothyroxine
MEDRTD013971ThyrotoxicosisDISEASEmay_treatlevothyroxine
MEDRTD013971ThyrotoxicosisDISEASEci_withlevothyroxine sodium
MEDRTD013971ThyrotoxicosisDISEASEmay_treatlevothyroxine sodium
MEDRTD013971ThyrotoxicosisDISEASEci_withlevothyroxine
MEDRTN0000000237Thyroid Hormone Receptor AgonistsMOAhas_moalevothyroxine
MEDRTN0000000237Thyroid Hormone Receptor AgonistsMOAhas_moalevothyroxine sodium
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_pelevothyroxine
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_pelevothyroxine sodium
MEDRTN0000009340Increased GluconeogenesisPEhas_pelevothyroxine
MEDRTN0000009340Increased GluconeogenesisPEhas_pelevothyroxine sodium
MEDRTN0000009399Increased Metabolic RatePEhas_pelevothyroxine
MEDRTN0000009399Increased Metabolic RatePEhas_pelevothyroxine sodium

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESRXNAV_VET_DRUGUS
ATTRIBUTESVET_DRUGUS
CODESNADANADA141448
NAMESPrescribable SynonymThyro-Tabs Canine 0.8 MG Oral Tablet
SOURCESSourceMetathesaurus FDA Structured Product Labels